We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

117 hedge funds and large institutions have $19.2M invested in Sanofi Contingent Value Rights in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 116 → 117 (+1)

0% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 21

71% less capital invested

Capital invested by funds: $66.6M → $19.2M (-$47.4M)

Holders
117
Holders Change
+1
Holders Change %
+0.86%
% of All Funds
3.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
11
Increased
21
Reduced
21
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$662K
2
GCM
Gruss Capital Management
New York
+$510K
3
PC
Pomelo Capital
New York
+$416K
4
WA
Whitebox Advisors
Minnesota
+$365K
5
DAM
Deltec Asset Management
New York
+$295K

Top Sellers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
-$428K
2
CPA
Columbia Pacific Advisors
Washington
-$166K
3
MCM
Moore Capital Management
New York
-$83.4K
4
IRF
IBM Retirement Fund
New York
-$49K
5
Millennium Management
Millennium Management
New York
-$41K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Whitebox Advisors
Minnesota
$4.04M +$365K +1,073,921 +5%
EM
2
Elliott Management
New York
$3.77M +$203K +596,100 +3%
MCM
3
Mason Capital Management
New York
$2.78M – – –
CPM
4
Chesapeake Partners Management
Maryland
$1.6M +$17K +50,000 +0.6%
GCM
5
Gruss Capital Management
New York
$1.05M +$510K +1,500,000 +38%
OAM
6
Oxford Asset Management
United Kingdom
$955K – – –
COPPSERS
7
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$604K – – –
CL
8
CSS LLC
Illinois
$500K – – –
DAM
9
Deltec Asset Management
New York
$376K +$295K +866,782 +78%
SCM
10
Stonehill Capital Management
New York
$370K +$662K +1,945,339 New
Citigroup
11
Citigroup
New York
$295K +$2 +7 +0%
Brown Advisory
12
Brown Advisory
Maryland
$271K +$1.22K +3,586 +0.3%
MFP
13
Michael F. Price
$252K +$16.3K +48,043 +4%
PC
14
Pomelo Capital
New York
$233K +$416K +1,223,054 New
UOC
15
UBS O'Connor
Illinois
$232K +$2.25K +6,619 +0.5%
Millennium Management
16
Millennium Management
New York
$190K -$41K -120,577 -11%
CLOS
17
Compagnie Lombard Odier SCmA
Switzerland
$190K – – –
MCM
18
Moore Capital Management
New York
$142K -$83.4K -245,100 -25%
GF
19
Gabelli Funds
New York
$133K +$68K +200,000 +40%
ACM
20
Akanthos Capital Management
California
$127K +$56.8K +167,000 +33%
Adage Capital Partners
21
Adage Capital Partners
Massachusetts
$117K – – –
Bank of America
22
Bank of America
North Carolina
$92K +$1.84K +5,397 +1%
BMO
23
Beck Mack & Oliver
New York
$91K -$17 -50 -0%
FCM
24
Farmstead Capital Management
New Jersey
$88K – – –
TA
25
Teton Advisors
New York
$76K – – –
1
2 3 4

GCVRZ Hedge Fund Activity: Q3 2015 in Review

117 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2015, worth a combined $19.2M — down 71% from $66.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GCVRZ positions and 10 closed out — a net gain of 1 holder — while 21 added to existing stakes and 21 trimmed.

The largest buyer was Stonehill Capital Management, opening a new position worth an estimated $662K. The largest seller was Park West Asset Management, exiting entirely with an estimated $428K sold.

  • 117 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2015, up from 116 in Q2 2015.
  • Funds reported $19.2M of Sanofi Contingent Value Rights stock for Q3 2015, down 71% quarter-over-quarter.
  • 11 funds opened new Sanofi Contingent Value Rights positions in Q3 2015 and 10 closed out, a net change of +1 holder.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2015 was Stonehill Capital Management, an estimated $662K added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2015 was Park West Asset Management, an estimated $428K sold.

Based on aggregated 13F filings for Q3 2015.